Our lab studies dysregulated signaling networks that are characteristic of cancer and disease.  Specifically, we use proteomics and genomics to characterize adaptive responses of tumors to targeted kinase inhibitors.

My work has been focused on the adaptive responses and acquisition of resistance to targeted inhibitors in cancer.

Past Affiliations

Member, Herman B. Wells Center for Pediatric Research, Centers and Institutes, Indiana University School of Medicine

Research Assistant Professor, Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill (past)

Oncology, Pediatrics, Pediatrics
PhD, University of Cincinnati, Cell and Molecular Biology, 2003
MS, Miami University, Zoology, 1999
BA, Miami University, Zoology and Chemistry, 1997